Patritumab Deruxtecan Biosimilar - Research Grade
Product Specifications
Background
Anti-ERBB3/ HER3 Reference Antibody (Patritumab deruxtecan) is a novel ADC composed of an anti-HER3 antibody (Patritumab) and a novel potent topoisomerase I inhibitor DX-8951, conjugated, on an average of 8 cysteinyl, to deruxtecan, comprising a linker and a camptothecin derivative.
Product Name Alternative
Dxd
Host
CHO Cells
Reactivity
Human
Target
ERBB3 / HER3
Isotype
IgG1
Applications
Functional Assays
Concentration
1mg/mL
Purity
>90% by SDS-PAGE
Shipping Conditions
Room Temp
Storage Conditions
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Formulation
25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)
Applications Notes
Reconstitute with sterile, distilled water to a final concentration of 1 mg/ml. Gently shake to solubilize completely. Do not vortex.
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
